Independent Advisor Alliance Has $678,000 Stake in Humana Inc. (NYSE:HUM)

Independent Advisor Alliance increased its stake in shares of Humana Inc. (NYSE:HUMFree Report) by 68.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,141 shares of the insurance provider’s stock after buying an additional 869 shares during the quarter. Independent Advisor Alliance’s holdings in Humana were worth $678,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV grew its position in Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after buying an additional 61 shares in the last quarter. CarsonAllaria Wealth Management Ltd. grew its position in Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after buying an additional 39 shares in the last quarter. Atwood & Palmer Inc. acquired a new stake in Humana during the third quarter worth approximately $29,000. Ashton Thomas Securities LLC acquired a new stake in Humana during the third quarter worth approximately $31,000. Finally, Your Advocates Ltd. LLP grew its position in Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after buying an additional 45 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Performance

Shares of Humana stock opened at $296.83 on Thursday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The business has a 50-day moving average price of $275.91 and a two-hundred day moving average price of $330.00. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $526.47. The company has a market cap of $35.74 billion, a P/E ratio of 26.29, a PEG ratio of 2.40 and a beta of 0.52.

Humana (NYSE:HUMGet Free Report) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, analysts anticipate that Humana Inc. will post 15.86 EPS for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a $0.885 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.19%. Humana’s dividend payout ratio is presently 31.36%.

Wall Street Analyst Weigh In

Several research firms have weighed in on HUM. Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and upped their target price for the stock from $247.00 to $308.00 in a research note on Wednesday, November 6th. UBS Group cut their target price on Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, October 4th. Leerink Partnrs cut Humana from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. KeyCorp began coverage on Humana in a research note on Friday, October 11th. They set a “sector weight” rating for the company. Finally, Deutsche Bank Aktiengesellschaft cut their target price on Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research note on Thursday, October 3rd. Twenty investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, Humana has an average rating of “Hold” and an average price target of $315.86.

Read Our Latest Analysis on Humana

Humana Company Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

See Also

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.